Cite
APA Citation
Herrera, A. F., Goy, A., Mehta, A., Ramchandren, R., Pagel, J. M., Svoboda, J., Guan, S., Hill, J. S., Kwei, K., Liu, E. A., & Phillips, T. (n.d.). safety and activity of ibrutinib in combination with durvalumab in patients with relapsed or refractory follicular lymphoma or diffuse large B‐cell lymphoma. American journal of hematology, 95(1), 18–27. http://access.bl.uk/ark:/81055/vdc_100098071997.0x000041